November 2025 in “Turkish Journal of Dermatology” Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.
15 citations
,
January 2024 in “Journal of Materials Chemistry B” The hydrogel speeds up wound healing and improves skin repair better than commercial options.
2-Hydroxy-1,4-naphthoquinone is a strong 5α-reductase inhibitor.
November 2022 in “Journal of Investigative Dermatology” Statins may help treat alopecia areata by reducing harmful immune interactions.
17 citations
,
January 2011 in “The Korean Journal of Hepatology” Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.
January 2013 in “프로그램북(구 초록집)” Systemic agents like cyclosporine, methotrexate, and acitretin help manage psoriasis but have significant side effects.
Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.
Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.
2 citations
,
February 2025 in “Archives of Dermatological Research” Baricitinib is a safe and effective alternative for alopecia areata patients who do not respond to tofacitinib.
16 citations
,
March 2017 in “Oncotarget” SOCS3 treatment can prevent hair loss by stopping harmful immune responses.